Article Sidebar

pdf
Date Published: 15/02/2024
Abstract Views: 276
Views pdf: 179
DOI: https://doi.org/10.51298/vmj.v535i1B.8460
Issue
Vol. 535 No. 1B (2024)
Section
Các bài báo
How to Cite
Nguyễn, T., Lê, M. H., Nguyễn, T. T. T., & Trương, P. T. (2024). SCLERODERMA TREATMENT WITH TRADITIONAL MEDICINE: A CASE REPORT AND LITERATURE REVIEW. Vietnam Medical Journal, 535(1B). https://doi.org/10.51298/vmj.v535i1B.8460

SCLERODERMA TREATMENT WITH TRADITIONAL MEDICINE: A CASE REPORT AND LITERATURE REVIEW

Trí Nguyễn, Minh Hoàng Lê, Thị Thanh Trúc Nguyễn, Phương Thảo Trương

Main Article Content

Abstract

Background: Scleroderma, a chronic autoimmune disorder of unknown etiology, lacks specific treatment options and is primarily managed by symptom control. Although medical literature and recent publications show that the effectiveness of combining Traditional Medicine and Modern Medicine in treatment brings good results, studies on scleroderma treatment using Traditional medicine in Vietnam are still limited. Therefore, in the case of effective treatment of scleroderma by combining Traditional Medicine and Modern Medicine, we present a clinical case report. Method: After diagnosing a 50-year-old male patient with symptoms of systemic sclerosis, we collected clinical and paraclinical indicators and observed the treatment process using Traditional medicine and Modern medicine. Results: After 30 days of treatment, there was a noticeable improvement in symptoms. The modified Rodnan skin score (mRSS) remarkably improved, decreasing from 45/51 to 25/51; the VAS score decreased from 6 to 3; Improved skin pigmentation and symptoms according to Traditional Medicine. Conclusions: The treatment of combining modern medicine and traditional medicine in scleroderma brings good results, improving the patient's quality of life.

Article Details

Keywords

Scleroderma, Traditional medicine, case report.

References

Bộ Y Tế. Bệnh xơ cứng bì hệ thống. Hướng dẫn chẩn đoán và điều trị các bệnh da liễu. 2023;139-147.
2. Trọng N. Hướng dẫn chẩn đoán và trị bệnh da liễu. Nhà xuất bản Y học. 2019;199-203.
3. Denton C.P., M. Hughes, N. Gak, et al. BSR and BHPR guideline for the treatment of systemic sclerosis. Rheumatology (Oxford). 2016;55(10):1906-1910. doi: 10.1093/rheumatology/kew224.
4. Mouthon L, Berezné A, Guillevin L. Therapeutic options for systemic sclerosis related interstitial lung diseases. Respiratory Medicine. 2010;59-69. doi:10.1016/j.rmed.2010.03.018.
5. Jiehan Cui, et al. Efficacy and safety of mesenchymal stem cells in the treatment of systemic sclerosis: a systematic review and meta-analysis. Stem Cell Res Ther. 2022;13(1):118. doi: 10.1186/s13287-022-02786-3.
6. Kowal-Bielecka O, et al. Update of EULAR recommendations for the treatment of systemic sclerosis. Ann Rheum Dis. 2017;76(8):1327–1339. doi: 10.1136/annrheumdis-2016-209909.
7. 王文钰, 陈曦, 黄敏, 陈广山, 张梦鸽, & 段行武. 基于文献数据挖掘的硬皮病中医内治规律研究. 世界中医药. 2020;16(21):6. doi:10.3969/j.issn.1673-7202.2021.21.018
8. 胡心愿. 硬皮病中医辨证施治. 中国中医药现代远程教育. 2010;8(13):126-127. doi: 10.1969/ jium. 1672-2779.2010.13.106.
9. Xue Y, Zhao Y. Effects of the Mechanism of Traditional Chinese Medical Prescription-Yiqihuoxue Formula on Vasculopathy with Systemic Sclerosis. 2022;3(11):1408-1412.
10. Jia-Qian Zhang, et al. Application of integrated traditional Chinese and Western medicineinthetreatment of juvenile localized scleroderma with skin ulcer: a case report. Clinical Research Communications. 2023;6(3):16.